reality check, page-5

The reality check is the share price is about where it should be. This company will remain speculative until we have a proven high volume production line up and running and firm volume orders from Sanofi. Nothing in the last update would make me invest in the Company unless i was a speculator looking for risk, reward. Yes all appears on track but there is still a lot that could go wrong( they are still modifying the production line for example). If Sanofi decided to pull out of their agreement for any reason we are left with a big factory and a small 1ml production line which in AS own words isnt a company maker.

I am confident, but still alert to potential downside and am not willing to invest more than i can afford to lose.

"Top up at these ridiculous prices" is the catch cry but IMO do so with both eyes open.